+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of lianhuaqingwen capsules on airway inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease



Effect of lianhuaqingwen capsules on airway inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease



Evidence-BasedComplementaryandAlternativeMedicine2014:637969



Chronic obstructive pulmonary disease (COPD) is characterized by a chronic inflammatory response that is worsened by acute exacerbations. Lianhuaqingwen (LHQW) has anti-inflammatory and immune regulatory functions and may inhibit the airway inflammation that occurs during an acute exacerbation of COPD. In this study, 100 participants were recruited and randomly assigned, 1 : 1, to the LHQW and the conventional groups, which were treated, respectively, with LHQW capsules and conventional Western medicine or only conventional Western medicine. The scores of the CAT scale and levels of inflammatory cytokines in blood and sputum were measured during treatment. In addition, subjects were subdivided into high-risk and low-risk subgroups. The CAT scores in the LHQW group and high-risk subgroup were clearly improved from the 5th day, but the other groups improved only after treatment was completed. Expression levels of IL-8, TNF- α , IL-17, and IL-23 in the sputum and of IL-8 and IL-17 in the blood were significantly decreased after treatment, and similar results were found in subgroups. These data suggested that LHQW capsules can accelerate the improvement of AECOPD patients, especially for the high-risk subgroup, and the mechanism of action may be related to the decreased release of inflammatory mediators.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052814574

Download citation: RISBibTeXText

PMID: 24971150

DOI: 10.1155/2014/637969


Related references

Effect of airway clearance techniques in patients experiencing an acute exacerbation of chronic obstructive pulmonary disease: a systematic review. Chronic Respiratory Disease 7(1): 9-17, 2010

A study of the mechanism of Qingre Huatan therapy in treatment of acute exacerbation of chronic obstructive pulmonary disease by improving airway inflammation and mucus hypersecretion. Zhong Xi Yi Jie He Xue Bao 6(8): 799-805, 2008

The Relationship between Airway Inflammation and Exacerbation in Chronic Obstructive Pulmonary Disease. Tuberculosis and Respiratory Diseases 80(4): 325-335, 2017

Clinical effect of bi-level positive airway pressure ventilation on pulmonary encephalopathy of respiratory failure in acute exacerbation of chronic obstructive pulmonary disease. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 19(9): 558-559, 2007

Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 173(1): 71-78, 2006

Modulation of airway inflammation by Haemophilus influenzae isolates associated with chronic obstructive pulmonary disease exacerbation. Proceedings of the American Thoracic Society 3(6): 482-483, 2006

Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 162(3 Pt 1): 947-952, 2000

Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). American Journal of Respiratory and Critical Care Medicine 160(6): 1968-1975, 1999

The study on the value of using the chronic obstructive pulmonary disease and asthma physiology score to assess the severity of acute exacerbation in patients with chronic obstructive pulmonary disease complicated by type II respiratory failure. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 22(5): 275-278, 2010

Bacteriology in acute exacerbation in patients hospitalized frequently for acute exacerbation of chronic obstructive pulmonary disease. Zhonghua Yi Xue Za Zhi 94(10): 729-732, 2014

Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 10: 1265-1273, 2015

Effect of non-invasive NAVA on the patients with acute exacerbation of chronic obstructive pulmonary disease. Zhonghua Yi Xue Za Zhi 96(42): 3375-3378, 2016

Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease. Chinese Medical Journal 117(6): 828-834, 2004

Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 163(2): 349-355, 2001

Development of a Nomogram to Predict the Risk of 30-Day Re-Exacerbation for Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Copd 16(2): 160-167, 2019